A good night's sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...

It works by switching off nociceptors in the peripheral nervous system, and therefore preventing pain signals getting to the brain. This represents a potential new breakthrough in a world which has ...

The cerebral cortex is the largest part of a mammal's brain, and by some measures, the most important. In humans in particular, it's where most things happen—like perception, thinking, memory storage ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

After reading a recent Sun-Times investigation on opioid deaths among a generation of Black men, WBEZ editor Alden Loury ponders the role of racism and segregation in those deaths.

We are collecting data on people who have sought ibogaine treatment all around the world so we can start to collect a very ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

The US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.